{
  "id": 4905,
  "text": "[90] Lu Bꎬ Kumar Aꎬ Castellsagué Xꎬ et al.Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review ＆ meta￣analysis [J].BMC Infect Disꎬ 2011ꎬ 11: 13.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: [90] Lu Bꎬ Kumar Aꎬ Castellsagué Xꎬ et al.Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review ＆ meta￣analysis [J].BMC Infect Disꎬ 2011ꎬ 11: 13.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据分析，宫颈癌预防疫苗（如HPV疫苗）对于女性在预防人乳头瘤病毒（HPV）感染以及相关疾病（包括宫颈癌前病变和宫颈癌）方面具有良好的疗效和安全性。研究显示，HPV疫苗能够显著降低与高危型HPV病毒相关的疾病风险，尤其是在未曾感染HPV的女性中接种效果最佳。\n\n关于安全性，大规模系统评价表明，宫颈癌预防疫苗总体具有良好的耐受性。虽然接种后可能会出现轻微的不良反应（如注射部位疼痛、发红及短暂的头痛等），但未发现显著的严重副作用。\n\n综合来看，宫颈癌预防疫苗为女性在预防相关疾病提供了一种有效且安全的措施，特别适合9至26岁尚未接触HPV感染的女性进行接种。同时，定期筛查与疫苗接种相结合能够更有效地降低宫颈癌的发生率。",
  "query": "**什么是宫颈癌预防疫苗在女性中的疗效和安全性？**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: **什么是宫颈癌预防疫苗在女性中的疗效和安全性？**\n\n<reference text>: [90] Lu Bꎬ Kumar Aꎬ Castellsagué Xꎬ et al.Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review ＆ meta￣analysis [J].BMC Infect Disꎬ 2011ꎬ 11: 13.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据分析，宫颈癌预防疫苗（如HPV疫苗）对于女性在预防人乳头瘤病毒（HPV）感染以及相关疾病（包括宫颈癌前病变和宫颈癌）方面具有良好的疗效和安全性。研究显示，HPV疫苗能够显著降低与高危型HPV病毒相关的疾病风险，尤其是在未曾感染HPV的女性中接种效果最佳。\n\n关于安全性，大规模系统评价表明，宫颈癌预防疫苗总体具有良好的耐受性。虽然接种后可能会出现轻微的不良反应（如注射部位疼痛、发红及短暂的头痛等），但未发现显著的严重副作用。\n\n综合来看，宫颈癌预防疫苗为女性在预防相关疾病提供了一种有效且安全的措施，特别适合9至26岁尚未接触HPV感染的女性进行接种。同时，定期筛查与疫苗接种相结合能够更有效地降低宫颈癌的发生率。"
}